RecruitingPHASE2, PHASE3NCT06897839
Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Airway Therapeutics, Inc.
- Intervention
- Air-sham(other)
- Enrollment
- 366 enrolled
- Eligibility
- All sexes
- Timeline
- 2025 – 2030
Study locations (20)
- Bnai Zion Medical Center, Haifa, Israel
- Shaare-Zedek Medical Center, Jerusalem, Israel
- Ziv Medical Center, Safed, Israel
- IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola, Bologna, Italy
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
- Ospedale dei Bambini "V. Buzzi", Milan, Italy
- Azienda Ospedale Università di Padova, Padua, Italy
- Hospital General Universitario de Alicante Dr. Balmis, Alicante, Spain
- Hospital Clínic de Barcelona, Barcelona, Spain
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Hospital Sant Joan de Déu, Barcelona, Spain
- Hospital Universitario Cruces - OSI Ezkerraldea-Enkarterri-Cruces, Bilbao, Spain
- Hospital Universitario Puerta del Mar, Cadiz, Spain
- Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain
- Hospital General Universitario Gregorio Marañón, Madrid, Spain
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06897839 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGPHASE1NCT06589245Inhaled Ciclesonide Study in Preterm InfantsVenkatesh Sampath